-+ 0.00%
-+ 0.00%
-+ 0.00%

Sinopharm Hyundai (600420.SH): Tacrolimus ointment obtained drug registration certificate

Zhitongcaijing·09/18/2026 08:25:02
Listen to the news

Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” for tacrolimus ointment approved and issued by the State Drug Administration. Tacrolimus ointment is a non-hormonal immunomodulatory drug. It is suitable for patients with moderate to severe atopic dermatitis who are unfit to use traditional treatments due to potential risks, or who do not respond adequately to traditional treatments, or cannot tolerate traditional treatments. It can be used as a short-term or intermittent long-term treatment. 0.03% concentration can be used for children 2 years and older.